The Yield Growth Corp. (CSE:BOSS, OTCQB:BOSQF, FSE:YG3) is pleased to announce that on November 21, 2019 it entered into an addendum agreement to add the territories of Costa Rica, El Salvador, Ecuador, Argentina, Panama and Peru to its existing distribution agreement with Organic Medical Growth OMG3 Inc. (“OMG3”) for the exclusive distribution of Urban Juve products in Colombia and Brazil for a term of 5 years.

yield growth


Yield Growth expands distribution of Urban Juve line in South America to include Costa Rica, El Salvador, Ecuador, Argentina, Panama, Peru, Colombia and Brazil

OMG3 is in the process of distributing Urban Juve hemp-infused products in Colombia and other countries of Central and Latin America. The first products to be offered will be Urban Juve’s Face Moisturizers and its signature Anti-Aging Serum. The first purchase order for 3,500 units has been placed and will be delivered once the products are registered for sale in Colombia. Registration of these products in Colombia is expected to be completed in early 2020.

OMG3, through an exclusive 10-year distribution agreement, has access to more than 9,000 points of sale in Colombia (pharmacies and specialized stores). Through the same distribution partner, OMG3 can reach more than 44,000 retail locations in other countries in South America, including Brazil, Costa Rica, Panama, Argentina, El Salvador, Ecuador and Peru. Yield Growth and OMG3 have now expanded their distribution agreement to cover all of these territories.

In addition to this channel, OMG has partnered with LATAM’s on-demand delivery giant Rappi, as the first to have its cannabis products available on the platform across Colombia. Rappi was founded in Colombia in 2015 and has become the unicorn of the LATAM start up scene having just received $1 billion in venture capital funding from Softbank. Rappi is located in 55 cities across 7 LATAM countries including Brazil, Argentina, Chile, Colombia, Peru, Uruguay, and Mexico and plans to expand to 100 new cities by the end of 2019. OMG has signed an exclusive agency agreement with Ariadna, LATAM’s largest independent marketing communications group based in Colombia, with a regional team of over 700 specialists in 15 countries and delivering services to 22 countries in the Americas. With cannabis being such a new emerging industry, OMG will be utilizing Ariadna’s skills to build its data technology, measure consumer behaviour and build a data centre that will prove valuable for the successful activation of OMG’s products into the various markets and channels across LATAM. Ariadna will build campaigns for OMG that will influence its brand reputation and brand equity in LATAM. From traditional-digital media planning to search, affiliate marketing, content amplification, ecommerce and influencer products, OMG will immediately capture all of its data to build what is nonexistent in LATAM in the cannabis category today.

“We are very pleased to welcome Urban Juve to our distribution portfolio and exclusively distribute their products in South and Central America. In addition to creating in-house and co-branded hemp seed and cannabis-based product lines, our strategy is to bring major international brands to the market in the areas of cosmetics, therapeutic and pharmaceutical products,” says Jorge Diaz, President & CEO of OMG3. “We strongly believe that the Urban Juve products will be an excellent addition to the current retail offer, finding their way to customers across borders due to their natural formulas and benefits. Urban Juve products will be initially distributed in Colombia, and we look forward to working with their team on expanding the reach within our network throughout the Americas.”

According to Goldstein Research, the Latin America cosmetics market reached a value of USD $31.98 billion in 2017 and is anticipated to grow at a CAGR of 4.49% during the forecast period 2017-2025.

Urban Juve products are now fully registered for sale in the European Union and are for sale in retail stores in Canada and the U.S. Agreements are in place to distribute Urban Juve in Canada, Greece, Cyprus, Romania, Bulgaria, Serbia, Colombia, Brazil and now also Costa Rica, Panama, Argentina, El Salvador, Ecuador and Peru. Yield Growth is currently in talks with distributors to add the United Kingdom, Germany and other European countries to the Urban Juve distribution network.

About Organic Medical Growth OMG3 Inc.

Organic Medical Growth OMG3 Inc. (“OMG”, or “Company”) is a Canadian company with a fully integrated cannabis operation in Colombia, established to produce the lowest cost GAP and GMP certified product and distribute cannabis consumer product goods to the largest retail and ecommerce

distribution network throughout Latin America (“LATAM”). Through its Colombian partner Ortix, and its 100% owned controlled subsidiary OMG Colombia, OMG has access to a proven distribution channel of over 44,000 pharmacies and has partnered with on-demand delivery giant, Rappi, as the first company to sell cannabis-derived products through their e-commerce platform. Part of the strategic direction for the company will be a creation of its own e-commerce platform. OMG is equipped with world-class cannabis and products experts. To implement, oversee and execute its production, the company boasts internationally recognized industrial-scale breeders, cultivators and extractors. Coupled with consumer product goods activators who have worked with leading global brands, OMG brings decades of experience to ensure that its integrated model is a competitive advantage. OMG3 also owns 100% of Estado Verde S.A.S, a Colombian company that has cannabis related licenses and permits, including the License for the cultivation of Psychoactive Cannabis (THC) and the License for the cultivation of Non-Psychoactive Cannabis (CBD). The company has entered into a joint venture for a 4,000 hectares hemp production in Colombia. OMG3 is positioning itself to become the largest producer and distributor of cannabis products in South America.

About The Yield Growth Corp.

The Yield Growth Corp. is developing and selling hemp, marijuana and mushroom products in what the Global Wellness Institute reports is a $4.2 trillion-dollar global wellness market. It owns the cannabis wellness brands Urban Juve, Wright & Well and Jack n Jane. The Yield Growth management team has deep experience with global brands including Johnson & Johnson, Procter & Gamble, M·A·C Cosmetics, Skechers and Aritzia. Its all natural hemp skincare brand, Urban Juve, has signed distribution agreements in Canada, Colombia, Brazil, Greece, Cyprus, Bulgaria, Romania and Serbia. Yield Growth’s Wright & Well brands are launching a THC/CBD line of topical and edible products in Oregon this month and a CBD from hemp topicals line in California in 2020. Through its subsidiaries, Yield Growth has over 200 proprietary beauty, wellness, edibles and beverage formulas for commercialization. It has filed 12 patents to protect its extraction method and formulas. Yield Growth is in revenue through multiple streams including licensing, services and product sales.

For more information about Yield Growth, visit www.yieldgrowth.com or follow @yieldgrowth on Instagram. Visit www.urbanjuve.com and #findyourjuve across social platforms to learn, engage and shop.

Investor Relations Contacts:

Penny White, President & CEO

Kristina Pillon, Investor Relations

invest@yieldgrowth.com

1-833-514-BOSS 1-833-514-2677
1-833-515-BOSS 1-833-515-2677

The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, intellectual property protection, and sale of, and demand for, Urban Juve, Wright & Well, Flourish Mushroom Labs, Jack n Jane and UJ Beverages products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

Click here to connect with Yield Growth Corp. (CSE:BOSS) for an Investor Presentation.

Source

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less